Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Terminated 3Completed 3Recruiting 1Active not recruiting 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1CNS 1

Conditions

Small Cell Lung Carcinoma 8Neuroblastoma 5Rhabdoid Tumor 3Ovarian Neoplasms 3Neoplasms 3Fallopian Tube Neoplasms 3Neoplasm Metastasis 2Uterine Cervical Neoplasms 1Thrombocythemia, Essential 1Sarcoma, Ewing 1Sarcoma 1SCLC 1Rhabdomyosarcoma 1Retinoblastoma 1Recurrence 1Primary Myelofibrosis 1Polycythemia Vera 1Pancreatic Neoplasms 1Myelodysplastic-Myeloproliferative Diseases 1Medulloblastoma 1Lung Neoplasms 1Leukemia, Myelomonocytic, Chronic 1Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative 1Leukemia, Myeloid, Acute 1Fallopian Tube Mucinous Adenocarcinoma 1Epilepsy 1Diffuse Intrinsic Pontine Glioma 1Choroid Plexus Neoplasms 1Central Nervous System Neoplasms 1Carcinoma, Neuroendocrine 1

Interventions

Magnetic Resonance Spectroscopy 9Cyclophosphamide 8Specimen Handling 7X-Rays 6Phantoms, Imaging 6Vincristine 5Nuclear Medicine Department, Hospital 5Cisplatin 5Temozolomide 4Radiotherapy 4Biopsy 4Lomustine 3Etoposide 3Carboplatin 3ulixertinib 2tipifarnib 2selpercatinib 2pembrolizumab 2palbociclib 2larotrectinib 2ivosidenib 2erdafitinib 2ensartinib 2Radiation 2Platinum 2Irinotecan 21,2-diaminocyclohexaneplatinum II citrate 2tazemetostat 1omburtamab I-131 1olaparib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Active not recruiting × Medulloblastoma × Topotecan × Clear all
NCT03709680 2025-01-14

Study Of Palbociclib Combined With Chemotherapy In Pediatric Patients With Recurrent/Refractory Solid Tumors

Pfizer

Phase 2 Active not recruiting
128 enrolled
CNSSarcoma

Diffuse Intrinsic Pontine Glioma, Bone Neoplasms, Medulloblastoma, Neoplasms, Neuroblastoma, Rhabdomyosarcoma, Sarcoma, Sarcoma, Ewing, Rhabdoid Tumor

Data powered by HemOnc (CC BY 4.0) Colophon âš¡